Nakajima T - Search Results

1

Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma.

Tomizawa Y, Kohno T, Fujita T, Kiyama M, Saito R, Noguchi M, Matsuno Y, Hirohashi S, Yamaguchi N, Nakajima T, Yokota J. Tomizawa Y, et al. Among authors: nakajima t. Oncogene. 1999 Jan 28;18(4):1007-14. doi: 10.1038/sj.onc.1202384. Oncogene. 1999. PMID: 10023676

2

Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma.

Tomizawa Y, Nakajima T, Kohno T, Saito R, Yamaguchi N, Yokota J. Tomizawa Y, et al. Among authors: nakajima t. Cancer Res. 1998 Dec 1;58(23):5478-83. Cancer Res. 1998. PMID: 9850082

3

The p16 (CDKN2A) gene is involved in the growth of neuroblastoma cells and its expression is associated with prognosis of neuroblastoma patients.

Takita J, Hayashi Y, Nakajima T, Adachi J, Tanaka T, Yamaguchi N, Ogawa Y, Hanada R, Yamamoto K, Yokota J. Takita J, et al. Among authors: nakajima t. Oncogene. 1998 Dec 17;17(24):3137-43. doi: 10.1038/sj.onc.1202232. Oncogene. 1998. PMID: 9872329

4

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer.

Tomizawa Y, Iijima H, Sunaga N, Sato K, Takise A, Otani Y, Tanaka S, Suga T, Saito R, Ishizuka T, Dobashi K, Minna JD, Nakajima T, Mori M. Tomizawa Y, et al. Among authors: nakajima t. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6816-22. doi: 10.1158/1078-0432.CCR-05-0441. Clin Cancer Res. 2005. PMID: 16203769

5

Epigenetic inactivation of the RUNX3 gene in lung cancer.

Sato K, Tomizawa Y, Iijima H, Saito R, Ishizuka T, Nakajima T, Mori M. Sato K, et al. Among authors: nakajima t. Oncol Rep. 2006 Jan;15(1):129-35. Oncol Rep. 2006. PMID: 16328045

6

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.

Kaira K, Sunaga N, Tomizawa Y, Yanagitani N, Ishizuka T, Saito R, Nakajima T, Mori M. Kaira K, et al. Among authors: nakajima t. Int J Oncol. 2007 Jul;31(1):169-73. Int J Oncol. 2007. PMID: 17549418

7

Comparison of the efficacy of radiotherapy between postoperative mediastinal lymph node recurrence and stage III disease in non-small cell lung cancer patients.

Imai H, Murakami H, Yoshino R, Mori K, Sumita K, Ono A, Akamatsu H, Taira T, Kenmotsu H, Harada H, Naito T, Kaira K, Tomizawa Y, Ohde Y, Matsuura M, Endo M, Saito R, Nakajima T, Takahashi T. Imai H, et al. Among authors: nakajima t. J BUON. 2016 Mar-Apr;21(2):333-40. J BUON. 2016. PMID: 27273942 Free article.

8

Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer.

Tomizawa Y, Iijima H, Nomoto T, Iwasaki Y, Otani Y, Tsuchiya S, Saito R, Dobashi K, Nakajima T, Mori M. Tomizawa Y, et al. Among authors: nakajima t. Lung Cancer. 2004 Dec;46(3):305-12. doi: 10.1016/j.lungcan.2004.05.003. Lung Cancer. 2004. PMID: 15541815

9

The cyclin-dependent kinase inhibitor p27 as a prognostic factor in advanced non-small cell lung cancer: its immunohistochemical evaluation using biopsy specimens.

Ishihara S, Minato K, Hoshino H, Saito R, Hara F, Nakajima T, Mori M. Ishihara S, et al. Among authors: nakajima t. Lung Cancer. 1999 Dec;26(3):187-94. doi: 10.1016/s0169-5002(99)00085-9. Lung Cancer. 1999. PMID: 10598929

10

Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma.

Iijima H, Tomizawa Y, Dobashi K, Saito R, Nakajima T, Mori M. Iijima H, et al. Among authors: nakajima t. Br J Cancer. 2004 Sep 13;91(6):1143-8. doi: 10.1038/sj.bjc.6602005. Br J Cancer. 2004. PMID: 15292942 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,885 results

Search Page